Table 4.
Correlations between parameters in patients and controls at baseline.
| All Patients | n | r | p |
| CDI vs. TXB | 56 | 0.411 | <0.001 |
| CDI vs. BDNF | 52 | −0.5 | <0.001 |
| CDI vs. HCy | 58 | −0.2 | 0.081 |
| CDI vs. vitamin D | 56 | 0.036 | 0.396 |
| All patients | n | r | p |
| omega-6/omega-3 vs. TXB | 56 | 0.304 | 0.03 |
| omega-6/omega-3 vs. BDNF | 52 | −0.258 | 0.038 |
| omega-6/omega-3 vs. HCy | 58 | 0.08 | 0.282 |
| omega-6/omega-3 vs. vitamin D | 56 | −0.088 | 0.269 |
| Healthy Controls | n | r | p |
| omega-6/omega-3 vs. TXB | 19 | 0.520 | 0.01 |
| omega-6/omega-3 vs. BDNF | 19 | 0.174 | 0.471 |
| omega-6/omega-3 vs. HCy | 19 | 0.058 | 0.099 |
| omega-6/omega-3 vs. vitamin D | 18 | −0.028 | 0.915 |
CDI = Children’s Depression Inventory, TXB = thromboxane B, BDNF = brain-derived neurotrophic factor, HCy = homocysteine, vs. = versus, n = number of subjects, r = Spearman’s rank correlation coefficient, p = statistical significance, the numbers in the bold are statistically significant.